ECT in the treatment of a patient with Catatonia: Consent and complications

American Journal of Psychiatry

Volumn 167, Issue 2, 2010, Pages 127-132

  Zisselman, Marc H ^a   Jaffe, Richard L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMANTADINE; AMOBARBITAL; ANTINUCLEAR ANTIBODY; ARIPIPRAZOLE; BENZODIAZEPINE; BROMOCRIPTINE; CIPROFLOXACIN; CREATINE KINASE; DANTROLENE; ENOXAPARIN; GLYCOPYRRONIUM BROMIDE; HALOPERIDOL; LANSOPRAZOLE; LITHIUM CARBONATE; LORAZEPAM; MAGNESIUM; METHOHEXITAL; METHYLPREDNISOLONE; METOCLOPRAMIDE; METOPROLOL; NEOSTIGMINE; OLANZAPINE; RISPERIDONE; ROCURONIUM; SUXAMETHONIUM; UNINDEXED DRUG; VANCOMYCIN; ZIPRASIDONE; ZOLPIDEM;

ADULT; ALBUMIN BLOOD LEVEL; ALLERGIC REACTION; AUTONOMIC DYSFUNCTION; BACTERIAL INFECTION; BIPOLAR DISORDER; BRADYCARDIA; BREATHING RATE; CARDIOLOGY; CARDIOVERSION; CAREGIVER; CASE REPORT; CATATONIA; CEREBROSPINAL FLUID ANALYSIS; CLINICAL EVALUATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONSULTATION; CONTRACTURE; CREATINE KINASE BLOOD LEVEL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; DRUG BLOOD LEVEL; DRUG DOSE TITRATION; DRUG EFFECT; ECHOCARDIOGRAPHY; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAM; EMERGENCY WARD; EPILEPTIC STATE; EXTUBATION; EYE TRACKING; FEMALE; FEVER; FOLLOW UP; FOOD AVERSION; HEART ARRHYTHMIA; HEART RATE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYPERKALEMIA; HYPERTHERMIA; HYPOXIA; IMMOBILIZATION; INCIDENCE; INFORMED CONSENT; INTENSIVE CARE UNIT; INTUBATION; LABORATORY TEST; LEUKOCYTE COUNT; LOCKED IN SYNDROME; LUMBAR PUNCTURE; LUNG EMBOLISM; LUNG VENTILATION PERFUSION RATIO; MANIA; MANIC PSYCHOSIS; MENTAL HEALTH; MENTAL HOSPITAL; METABOLIC ACIDOSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MUSCLE INJURY; MUTISM; NASOGASTRIC TUBE; NEUROLEPTIC MALIGNANT SYNDROME; NURSING CARE; PARKINSONISM; PHYSIOTHERAPY; PRIORITY JOURNAL; PROTEIN ELECTROPHORESIS; QRS COMPLEX; RASH; RISK BENEFIT ANALYSIS; SEIZURE; SINUS RHYTHM; STIFF MAN SYNDROME; TEMPERATURE; TORSADE DES POINTES; TREATMENT OUTCOME; URINALYSIS; URTICARIA; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANDROSTANOLS; CATATONIA; ELECTRIC COUNTERSHOCK; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; NEUROMUSCULAR DEPOLARIZING AGENTS; NEUROMUSCULAR NONDEPOLARIZING AGENTS; SUCCINYLCHOLINE; THIRD-PARTY CONSENT; TORSADES DE POINTES; YOUNG ADULT;

EID: 75749101810     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2009.09050703     Document Type: Conference Paper

References (19)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed, Text Revision (DSM-IV-TR). Washington, DC, American Psychiatric Association, 2000
2. Bush G, Fink M, Petrides G, Dowling F, Francis A: Catatonia, I: rating scale and standardized examination. Acta Psychiatr Scand 1996; 93:129-136
3. Carroll BJ, Kirkhart R, Ahuja N, Soovere I, Lauterbach EC, Dhossche D, Talbert R: Katatonia: a new conceptual understanding of catatonia and a new rating scale. Psychiatry (Edgmont) 2008; 5:42-50
4. Fink M, Taylor MA: Catatonia: A Clinician's Guide to Diagnosis and Treatment. Cambridge, UK, Cambridge University Press, 2003
5. McCall WV, Mann SC, Shelp FE, Caroff SN: Fatal pulmonary embolism in the catatonic syndrome: two case reports and a literature review. J Clin Psychiatry 1995; 56:21-25
6. Levenson JL: Medical aspects of catatonia. Prim Psychiatry 2009; 16:23-26 7. Taylor MA, Fink M: Catatonia in psychiatric classification: a home of its own. Am J Psychiatry 2003; 160:1233-1241
7. McCall WV, Shelp FE, McDonald WM: Controlled investigation of the amobarbital interview for catatonic mutism. Am J Psychiatry 1992; 149:202-206
8. Thomas P, Cottencin O, Rasclec, Vaiva G, Goudemand M, Bieder J: Catatonia in French psychiatry: implications of the zolpidem challenge test. Psychiatr Ann 2007; 37:45-54
9. Babington PW, Spiegel DR: Treatment of catatonia with olanzapine and amantadine. Psychosomatics 2007; 48:534-536
10. Aboraya A, Chumber P, Altaha B: The treatment resistant catatonic patient. Curr Psychiatr 2009; 8:66-69
11. Slooter AJC, Braun KPJ, Balk FJE, Nieuwenhuizen O, van der Hoeven J: Electroconvulsive therapy for malignant catatonia in childhood. Pediatr Neurol 2005; 32:190-192
12. Espinola-Nadurille M, Ramirez-Bermudez J, Fricchione GL: Pregnancy and malignant catatonia. Gen Hosp Psychiatry 2007; 29:69-71
13. American Psychiatric Association Committee on Electroconvulsive Therapy: The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging, 2nd ed. Washington, DC, American Psychiatric Association, 2001
14. Abrams R: Electroconvulsive Therapy, 3rd ed. New York, Oxford University Press, 1997
15. Welch CA, Drop LJ: Cardiovascular effects of ECT. Convuls Ther 1989; 5:35-43
16. Waberski W, Fogg-Waberski J: Anesthesia for electroconvulsive therapy: a challenge for the 90s, in Advances in Anesthesia, vol 15. St Louis, Mosby-Year Book, 1998, pp 339-373
17. Gronert GA: Cardiac arrest after succinylcholine: mortality greater with rhabdomyolysis than receptor up-regulation. Anesthesiology 2001; 94:23-29
18. Martyn JA, Richtsfeld M: Succinylcholine-induced hyperkalemia in acquired pathological states: etiologic factors and molecular mechanisms. Anesthesiology 2006; 104:158-169
19. Hudcova J, Schumann R: Electroconvulsive therapy complicated by life threatening hyperkalemia in a catatonic patient. Gen Hosp Psychiatry 2006; 28:440-442